In addition, Professor David McEwan, University of East Anglia, will seat discussions on how experts from all over the world are targeting cancer treatments to ensure patients experience the most benefit .. British Pharmacological Society celebrates the start of annual meeting The British Pharmacological Society today celebrated the start of its annual meeting, which will cover the latest research in drug discovery over another three days, including a special focus on discoveries in cancer treatment. He BPS Winter Meeting attracts over 800 pharmacologists from around the world and is being held in London on 18-20 December 2012. ‘BPS members are focused on discovering and developing brand-new medicines.The study was published on the web today in Technology Translational Medicine. So, a combined approach could produce a much more powerful therapeutic effect eventually.
Arteriocyte awarded DARPA funding for company’s blood pharming technology Arteriocyte announced today a $1,950,000 award from DARPA for the business’s Nanofiber Based System technology for the Creation of Red Bloodstream Cells project. DARPA’s Bloodstream Pharming plan aims to develop an automated tradition and packaging system which will yield a easily available, donorless way to obtain universal donor red bloodstream cells in the military theatre. Arteriocyte is normally developing its NANEX technology in order to give a continuous manufacturing system to enable the elevated way to obtain universal donor red bloodstream units.